Publication | Open Access
Circulating tumor DNA in unresectable pancreatic cancer is a strong predictor of first-line treatment efficacy: The KRASCIPANC prospective study
16
Citations
37
References
2023
Year
ClinicalTrials.gov Identifier: NCT04560270.
| Year | Citations | |
|---|---|---|
Page 1
Page 1